228 related articles for article (PubMed ID: 25423036)
1. Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.
Vyazunova I; Maklakova VI; Berman S; De I; Steffen MD; Hong W; Lincoln H; Morrissy AS; Taylor MD; Akagi K; Brennan CW; Rodriguez FJ; Collier LS
PLoS One; 2014; 9(11):e113489. PubMed ID: 25423036
[TBL] [Abstract][Full Text] [Related]
2. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality.
Collier LS; Adams DJ; Hackett CS; Bendzick LE; Akagi K; Davies MN; Diers MD; Rodriguez FJ; Bender AM; Tieu C; Matise I; Dupuy AJ; Copeland NG; Jenkins NA; Hodgson JG; Weiss WA; Jenkins RB; Largaespada DA
Cancer Res; 2009 Nov; 69(21):8429-37. PubMed ID: 19843846
[TBL] [Abstract][Full Text] [Related]
3. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
Janik CL; Starr TK
J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
[TBL] [Abstract][Full Text] [Related]
4. Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions.
Largaespada DA; Collier LS
Methods Mol Biol; 2008; 435():95-108. PubMed ID: 18370070
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.
Restrepo A; Smith CA; Agnihotri S; Shekarforoush M; Kongkham PN; Seol HJ; Northcott P; Rutka JT
Neuro Oncol; 2011 Jan; 13(1):42-50. PubMed ID: 21075782
[TBL] [Abstract][Full Text] [Related]
6. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
7. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.
Bender AM; Collier LS; Rodriguez FJ; Tieu C; Larson JD; Halder C; Mahlum E; Kollmeyer TM; Akagi K; Sarkar G; Largaespada DA; Jenkins RB
Cancer Res; 2010 May; 70(9):3557-65. PubMed ID: 20388773
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC
Toxicol Pathol; 2000; 28(1):171-7. PubMed ID: 10669005
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system.
Garcia-Fabiani MB; Comba A; Kadiyala P; Haase S; Núñez FJ; Altshuler D; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 632():369-388. PubMed ID: 32000905
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
Hirvonen HE; Salonen R; Sandberg MM; Vuorio E; Västrik I; Kotilainen E; Kalimo H
Br J Cancer; 1994 Jan; 69(1):16-25. PubMed ID: 8286200
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.
Ohlfest JR; Demorest ZL; Motooka Y; Vengco I; Oh S; Chen E; Scappaticci FA; Saplis RJ; Ekker SC; Low WC; Freese AB; Largaespada DA
Mol Ther; 2005 Nov; 12(5):778-88. PubMed ID: 16150649
[TBL] [Abstract][Full Text] [Related]
12. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous development of intratumoral heterogeneity in a transposon-induced mouse model of glioma.
Sumiyoshi K; Koso H; Watanabe S
Cancer Sci; 2018 May; 109(5):1513-1523. PubMed ID: 29575648
[TBL] [Abstract][Full Text] [Related]
14. Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas.
Fukuyama K; Matsuzawa K; Hubbard SL; Dirks PB; Murakami M; Rutka JT
Anticancer Res; 1996; 16(3A):1251-7. PubMed ID: 8702246
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
16. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
Holland EC; Hively WP; DePinho RA; Varmus HE
Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
[TBL] [Abstract][Full Text] [Related]
17. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.
Tschida BR; Largaespada DA; Keng VW
Semin Cell Dev Biol; 2014 Mar; 27():86-95. PubMed ID: 24468652
[TBL] [Abstract][Full Text] [Related]
19. Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.
Clément-Schatlo V; Marino D; Burkhardt K; Teta P; Leyvraz F; Schatlo B; Frank S; Schaller K; Castella V; Radovanovic I
Neuro Oncol; 2012 Jun; 14(6):720-35. PubMed ID: 22584872
[TBL] [Abstract][Full Text] [Related]
20. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.
Carlson CM; Frandsen JL; Kirchhof N; McIvor RS; Largaespada DA
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17059-64. PubMed ID: 16286660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
